These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38188151)

  • 1. Borneol promotes autophagic degradation of HIF-1α and enhances chemotherapy sensitivity in malignant glioma.
    Lin L; Luo J; Wang Z; Cai X
    PeerJ; 2024; 12():e16691. PubMed ID: 38188151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
    Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oroxylin A increases the sensitivity of temozolomide on glioma cells by hypoxia-inducible factor 1α/hedgehog pathway under hypoxia.
    Wei M; Ma R; Huang S; Liao Y; Ding Y; Li Z; Guo Q; Tan R; Zhang L; Zhao L
    J Cell Physiol; 2019 Aug; 234(10):17392-17404. PubMed ID: 30790292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borneol promotes apoptosis of Human Glioma Cells through regulating HIF-1a expression via mTORC1/eIF4E pathway.
    Wang Z; Li Q; Xia L; Li X; Sun C; Wang Q; Cai X; Yang G
    J Cancer; 2020; 11(16):4810-4822. PubMed ID: 32626528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Borneol Induced Autophagy in Enhancing Radiosensitivity of Malignant Glioma.
    Li Q; Xia L; Sun C; Zhang H; Zheng M; Zhang H; Lu H; Wang Z
    Front Oncol; 2021; 11():749987. PubMed ID: 34917504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propofol enhances the sensitivity of glioblastoma cells to temozolomide by inhibiting macrophage activation in tumor microenvironment to down-regulate HIF-1α expression.
    Zhao W; Yun K
    Exp Cell Res; 2022 Sep; 418(2):113277. PubMed ID: 35810776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
    Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC
    Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis.
    Li T; Fu X; Wang J; Shang W; Wang X; Zhang L; Li J
    Oncol Res; 2023; 31(3):345-359. PubMed ID: 37305393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
    Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
    J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect and molecular mechanism of mTOR inhibitor rapamycin on temozolomide-induced autophagic death of U251 glioma cells.
    Li B; Zhou C; Yi L; Xu L; Xu M
    Oncol Lett; 2018 Feb; 15(2):2477-2484. PubMed ID: 29434961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.
    Wang N; Zhang Q; Ning B; Luo L; Fang Y
    Biomed Pharmacother; 2017 Jun; 90():368-374. PubMed ID: 28380412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage.
    Liu WJ; Yin YB; Sun JY; Feng S; Ma JK; Fu XY; Hou YJ; Yang MF; Sun BL; Fan CD
    Onco Targets Ther; 2018; 11():5429-5439. PubMed ID: 30233204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Far-infrared Ray on Temozolomide-treated Glioma in Rats.
    Chen JC; Hwang JH
    In Vivo; 2019; 33(4):1203-1208. PubMed ID: 31280210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
    J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway.
    Bu X; Qu X; Guo K; Meng X; Yang X; Huang Q; Dou W; Feng L; Wei X; Gao J; Sun W; Chao M; Han L; Hu Y; Shen L; Zhang J; Wang L
    Int J Biol Sci; 2021; 17(12):3013-3023. PubMed ID: 34421346
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
    Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Xu JX; Yang Y; Zhang X; Luan XP
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.